文献速递造血干细胞移植与细胞治疗

供者浆细胞样树突状细胞通过表达血管活性肠多肽限制移植物抗宿主病

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression.
PubMed 文献 · Blood · 2022-01-01

研究探讨供者浆细胞样树突状细胞(pDC)表达血管活性肠多肽(VIP)对移植物抗宿主病(GVHD)的影响。小鼠和人类pDC均表达VIP,VIP表达型pDC在体内外限制T细胞活化与扩增。在主要组织相容性复合体错配的同种异体骨髓移植中,与野生型pDC共移植相比,共移植VIP敲除pDC导致生存率降低、GVHD评分升高和结肠隐窝细胞凋亡增多。

要点

  • 小鼠和人类pDC均表达VIP,VIP表达型pDC在体内外限制T细胞活化与扩增。
  • 小鼠骨髓移植中供者pDC和T细胞向脾和肠道归巢模式相似。
  • 共移植VIP敲除pDC较野生型pDC导致更低生存率、更高GVHD评分和更多结肠隐窝细胞凋亡。

核心结论

  • 供者pDC通过旁分泌合成VIP限制致病性T细胞炎症,支持供者免疫细胞调控同种异体骨髓移植中T细胞活化和GVHD的新机制。

研究设计与样本

  • 研究采用小鼠和人类pDC的体内外模型系统,以及主要组织相容性复合体错配的同种异体小鼠骨髓移植模型。

主要发现

  • 小鼠和人类pDC表达VIP,VIP表达型pDC在体内外限制T细胞活化与扩增。
  • 小鼠骨髓移植中供者pDC和T细胞向脾和肠道归巢模式相似。
  • 与野生型pDC共移植相比,共移植VIP敲除pDC导致生存率降低、GVHD评分升高和结肠隐窝细胞凋亡增多。
  • 接受VIP敲除pDC的骨髓移植受者T辅助1极化T细胞增多,血浆粒细胞-巨噬细胞集落刺激因子和肿瘤坏死因子-α水平高于野生型pDC受者。
  • VIP敲除pDC受者的T细胞在移植后前2周bhlhe40转录本水平升高,第15天CyclophilinA/Ppia转录本水平高于野生型pDC受者T细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vasoactive intestinal polypeptide (VIP), an anti-inflammatory neuropeptide with pleiotropic cardiovascular effects, induces differentiation of hematopoietic stem cells into regulatory dendritic cells that limit graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplant (HSCT) recipients. We have previously shown that donor plasmacytoid dendritic cells (pDCs) in bone marrow (BM) donor grafts limit the pathogenesis of GVHD. In this current study we show that murine and human pDCs express VIP, and that VIP-expressing pDCs limit T-cell activation and expansion using both in vivo and in vitro model systems. Using T cells or pDCs from transgenic luciferase+ donors in murine bone marrow transplantation (BMT), we show similar homing patterns of donor pDCs and T cells to the major sites for alloactivation of donor T cells: spleen and gut. Cotransplanting VIP-knockout (KO) pDCs with hematopoietic stem cells and T cells in major histocompatibility complex mismatched allogeneic BMT led to lower survival, higher GVHD scores, and more colon crypt cell apoptosis than transplanting wild-type pDCs. BMT recipients of VIP-KO pDCs had more T helper 1 polarized T cells, and higher plasma levels of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α than recipients of wild-type pDCs. T cells from VIP-KO pDC recipients had increasing levels of bhlhe40 transcripts during the first 2 weeks posttransplant, and higher levels of CyclophilinA/Ppia transcripts at day 15 compared with T cells from recipients of wild-type pDCs. Collectively, these data indicate paracrine VIP synthesis by donor pDCs limits pathogenic T-cell inflammation, supporting a novel mechanism by which donor immune cells regulate T-cell activation and GVHD in allogeneic BMT.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Zhu J, Wang Y, Li J, et al. Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression. Blood. 2022. PMID: 35443019. doi:10.1182/blood.2021012561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。